Public Employees Retirement System of Ohio Has $27.60 Million Holdings in CVS Health Co. (NYSE:CVS)

Public Employees Retirement System of Ohio trimmed its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 3.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 614,924 shares of the pharmacy operator's stock after selling 20,872 shares during the period. Public Employees Retirement System of Ohio's holdings in CVS Health were worth $27,604,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. LaFleur & Godfrey LLC boosted its holdings in shares of CVS Health by 49.9% during the 4th quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator's stock worth $217,000 after buying an additional 1,610 shares during the period. Ballentine Partners LLC boosted its holdings in CVS Health by 17.5% in the 4th quarter. Ballentine Partners LLC now owns 5,314 shares of the pharmacy operator's stock valued at $239,000 after purchasing an additional 793 shares during the period. SG Americas Securities LLC boosted its holdings in CVS Health by 47.2% in the 4th quarter. SG Americas Securities LLC now owns 28,801 shares of the pharmacy operator's stock valued at $1,293,000 after purchasing an additional 9,234 shares during the period. Secure Asset Management LLC boosted its holdings in CVS Health by 13.8% in the 4th quarter. Secure Asset Management LLC now owns 33,271 shares of the pharmacy operator's stock valued at $1,494,000 after purchasing an additional 4,024 shares during the period. Finally, Southland Equity Partners LLC boosted its holdings in CVS Health by 44.0% in the 4th quarter. Southland Equity Partners LLC now owns 4,985 shares of the pharmacy operator's stock valued at $224,000 after purchasing an additional 1,523 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Up 0.8%

Shares of NYSE CVS traded up $0.50 during mid-day trading on Tuesday, hitting $61.33. The company's stock had a trading volume of 7,438,851 shares, compared to its average volume of 11,313,892. The stock has a market cap of $77.58 billion, a price-to-earnings ratio of 16.76, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The company's fifty day simple moving average is $66.01 and its 200-day simple moving average is $59.45.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.31 EPS. On average, sell-side analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.34%. CVS Health's dividend payout ratio (DPR) is currently 63.48%.

Insiders Place Their Bets

In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.

Analyst Ratings Changes

CVS has been the subject of a number of recent research reports. Barclays increased their price objective on shares of CVS Health from $73.00 to $82.00 and gave the company an "overweight" rating in a research note on Friday, May 2nd. Wolfe Research increased their price objective on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Cowen restated a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Truist Financial increased their price objective on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and a consensus price target of $74.94.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.